R. Hogezand

Double‐blind comparison of 5‐aminosalicylic acid and acetyl‐5‐aminosalicylic acid suppositories in patients with idiopathic proctitis

P. Wesseling, J. V. Tongeren, J. Gorp, 1988, Alimentary pharmacology & therapeutics.

Absorption of the oral bisphosphonate alendronate in osteoporotic patients with Crohn’s disease

J. Hartigh, S. Cremers, S. Papapoulos, 2005, Osteoporosis International.

Malignancies in Inflammatory Bowel Disease: Fact or Fiction?

C. Lamers, R. Veenendaal, R. V. Hogezand, 2002, Scandinavian journal of gastroenterology. Supplement.

Bacterial acetylation of 5-aminosalicylic acid in faecal suspensions cultured under aerobic and anaerobic conditions

J. Koopman, J. V. Tongeren, P. V. Hees, 2005, European Journal of Clinical Pharmacology.

Stability of disodium azodisalicylate (olsalazine) and metabolites in urine and faeces stored at different temperatures

J. V. Tongeren, P. V. Hees, R. V. Hogezand, 1988, European Journal of Drug Metabolism and Pharmacokinetics.

Disposition of Disodium Azodisalicylate in Healthy Subjects

B. Zwanenburg, J. V. Tongeren, P. V. Hees, 1985 .

Ileum resection is the most predictive factor for osteoporosis in patients with Crohn’s disease

A. Zwinderman, E. McCloskey, G. Griffioen, 2006, Osteoporosis International.